The group of Pierre van der Bruggen is a pioneer in the field of cancer immunotherapy and discovered the first human tumor antigens recognized by T lymphocytes. In close collaboration with clinicians, we aim to characterize the mechanisms of resistance to cancer immunotherapy, with a focus on myeloid-derived suppressor cells. The research group is part of the de Duve Institute, a multi-disciplinary and international biomedical research institute of the UCLouvain in Brussels.
Your mission
We are looking for a highly motivated candidate to pursue an exciting post-doc project in our lab, that is aimed at understanding how human myeloid-derived suppressor cells suppress the activity of immune cells, impede immunotherapy and favor tumor progression.
What we offer
Three-year postdoc fellowship.
ADDITIONAL INFORMATION
Selection process
Please send your application to Prof. Pierre van der Bruggen at pierre.vanderbruggen@uclouvain.be
The application should include:
1) a CV including previous research experience and publications;
2) a short cover letter (max. half a page) describing e.g. the candidate’s motivation, career objectives, research interests, expertise;
3) the name, affiliation and contact information of two references who can attest the quality and research interest of the candidate.
REQUIREMENTS
Offer Requirements
Skills/Qualifications
The candidate holds a PhD in Biological Sciences, Molecular/Cellular Biology, or equivalent. A strong immunology background is preferred. Knowledge in bioinformatic and statistic tools (e.g. shell coding and R language) are important. Experience with myeloid cells is a real plus.
A good command of English (spoken and written), good communication skills, good teamwork, and the ability to design, perform and analyze experiments independently are necessary.
Specific Requirements
The candidate is considered in “international mobility”, i.e. she/he has not resided, studied or worked in Belgium for more than 24 months over the past 3 years before the start of the post-doc.